Search

Your search keyword '"Lipitor (Medication) -- Evaluation"' showing total 2 results
Start Over Descriptor "Lipitor (Medication) -- Evaluation" Topic company business management
2 results on '"Lipitor (Medication) -- Evaluation"'

1. Blood work: Pfizer makes $800 million bid to reshape heart-care market; drug giant pins its hopes on treatment that boosts levels of good cholesterol; missing ingredient: olive oil

Author

Hensley, Scott and Winslow, Ron

Subjects
Pfizer Inc. -- Product development, Pharmaceutical industry -- Product development, Clinical trials -- Management, Cholesterol -- Drug therapy, Company business management, News, opinion and commentary, Lipitor (Medication) -- Evaluation, Torcetrapib (Medication) -- Testing
Published
2004

2. Pfizer Norway takes novel approach to reimbursement talks

Subjects
Pfizer Inc. -- Marketing, Prospective payment systems (Medical care) -- Management, Prospective payment systems (Medical care) -- Economic aspects, Pharmaceutical industry -- Marketing, Pharmaceutical industry -- Conferences, meetings and seminars, Company business management, Company marketing practices, Business, Pharmaceuticals and cosmetics industries, Lipitor (Medication) -- Evaluation
Abstract

Norwegian branch of Pfizer organized a meeting of over 100 medical and regulatory persons to highlight the benefits of switching to its cholesterol lowerer Lipitor (atorvastatin) from Merck Sharp & DhomeEs Zocor (simvastatin). Pfizer took the step in view of Norwegian Medicines AgencyEs move to examine the high reimbursement costs of statins.

Published
2004

Catalog

Books, media, physical & digital resources
See catalog results